Yixiao Zhang

Yixiao Zhang

Auto-generated profile, based on publicly available information

Yixiao Zhang

Interdisciplinary Research Center on Biology and Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 February 2021 in Nature
Verified
Journal Article
Closed access
PDF file
YZYixiao Zhang
Yixiao Zhang
CDCsaba Daday
Csaba Daday
RGRuo-Xu Gu
Ruo-Xu Gu
CCCharles D. Cox
Charles D. Cox
BMBoris Martinac
Boris Martinac
TWThomas Walz
Thomas Walz

3 April 2024 in Nature
Verified
Journal Article
Closed access
PDF file
YHYaoyao Han
Yaoyao Han
ZZZijing Zhou
Zijing Zhou
RJRuitao Jin
Ruitao Jin
FDFei Dai
Fei Dai
YGYifan Ge
Yifan Ge
YZYixiao Zhang
Yixiao Zhang

7 February 2020 in Science
Verified
Journal Article
Closed access
YSYadong Sun
Yadong Sun
YZYixiao Zhang
Yixiao Zhang
WAWei Shen Aik
Wei Shen Aik
XYXiao-Cui Yang
Xiao-Cui Yang
WMWilliam F. Marzluff
William F. Marzluff
LTLiang Tong
Liang Tong
Architecture of an mRNA processor: The 3′-end processing of the three major classes of RNA polymerase II transcripts in metazoan cells—polyadenylated messenger RNAs (mRNAs), histone mRNAs, and small nuclear RNAs (snRNAs)—requires three distinct machineries that share common features. Sun et al. reconstituted the active human histone pre-mRNA 3′-end processing machinery and solved its structure at near-atomic resolution by cryo–electron microscopy. This structure provides a basis for understanding the mechanism of the shared catalytic reactions between histone pre-mRNA and canonical pre-mRNA and snRNA 3′-end processing machineries. Science , this issue p. 700

18 August 2023 in Science
Verified
Journal Article
Closed access
ZZZijing Zhou
Zijing Zhou
XMXiaonuo Ma
Xiaonuo Ma
YLYiechang Lin
Yiechang Lin
DCDelfine Cheng
Delfine Cheng
NBNavid Bavi
Navid Bavi
CCCharles Cox
Charles Cox
Piezo channels are critical cellular sensors of mechanical forces. Despite their large size, ubiquitous expression, and irreplaceable roles in an ever-growing list of physiological processes, few Piezo channel–binding proteins have emerged. In this work, we found that MyoD (myoblast determination)–family inhibitor proteins (MDFIC and MDFI) are PIEZO1/2 interacting partners. These transcriptional regulators bind to PIEZO1/2 channels, regulating channel inactivation. Using single-particle cryogenic electron microscopy, we mapped the interaction site in MDFIC to a lipidated, C-terminal helix that inserts laterally into the PIEZO1 pore module. These Piezo-interacting proteins fit all the criteria for auxiliary subunits, contribute to explaining the vastly different gating kinetics of endogenous Piezo channels observed in many cell types, and elucidate mechanisms potentially involved in human lymphatic vascular disease.

2 October 2023 in BMC Biology
Verified
Journal Article
Open access
PDF file
AXAnqi Xia
Anqi Xia
XWXiaojie Wang
Xiaojie Wang
JHJiaying He
Jiaying He
WWWei Wu
Wei Wu
WJWeiyu Jiang
Weiyu Jiang
Qiao WangQiao Wang
Qiao Wang
Background: After the eradication of smallpox in China in 1979, vaccination with the vaccinia virus (VACV) Tiantan strain for the general population was stopped in 1980. As the monkeypox virus (MPXV) is rapidly spreading in the world, we would like to investigate whether the individuals with historic VACV Tiantan strain vaccination, even after more than 40 years, could still provide ELISA reactivity and neutralizing protection; and whether the unvaccinated individuals have no antibody reactivity against MPXV at all. Results: We established serologic ELISA to measure the serum anti-MPXV titer by using immunodominant MPXV surface proteins, A35R, B6R, A29L, and M1R. A small proportion of individuals (born before 1980) with historic VACV Tiantan strain vaccination exhibited serum ELISA cross-reactivity against these MPXV surface proteins. Consistently, these donors also showed ELISA seropositivity and serum neutralization against VACV Tiantan strain. However, surprisingly, some unvaccinated young adults (born after 1980) also showed potent serum ELISA activity against MPXV proteins, possibly due to their past infection by some self-limiting Orthopoxvirus (OPXV). Conclusions: We report the serum ELISA cross-reactivity against MPXV surface protein in a small proportion of individuals both with and without VACV Tiantan strain vaccination history. Combined with our serum neutralization assay against VACV and the recent literature about mice vaccinated with VACV Tiantan strain, our study confirmed the anti-MPXV cross-reactivity and cross-neutralization of smallpox vaccine using VACV Tiantan strain. Therefore, it is necessary to restart the smallpox vaccination program in high risk populations.

1 April 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
XZXindi Zhou
Xindi Zhou
HZHuijing Zhang
Huijing Zhang
YWYaru Wang
Yaru Wang
DWDanni Wang
Danni Wang
ZLZhiqiao Lin
Zhiqiao Lin
Lifeng PanLifeng Pan
Lifeng Pan
Ubiquitination plays vital roles in modulating pathogen-host cell interactions. RNF213, a E3 ligase, can catalyze the ubiquitination of lipopolysaccharide (LPS) and is crucial for antibacterial immunity in mammals. Shigella flexneri, an LPS-containing pathogenic bacterium, has developed mechanisms to evade host antibacterial defenses during infection. However, the precise strategies by which S. flexneri circumvents RNF213-mediated antibacterial immunity remain poorly understood. Here, through comprehensive biochemical, structural and cellular analyses, we reveal that the E3 effector IpaH1.4 of S. flexneri can directly target human RNF213 via a specific interaction between the IpaH1.4 LRR domain and the RING domain of RNF213, and mediate the ubiquitination and proteasomal degradation of RNF213 in cells. Furthermore, we determine the cryo-EM structure of human RNF213 and the crystal structure of the IpaH1.4 LRR/RNF213 RING complex, elucidating the molecular mechanism underlying the specific recognition of RNF213 by IpaH1.4. Finally, our cell based functional assays demonstrate that the targeting of host RNF213 by IpaH1.4 promotes S. flexneri proliferation within infected cells. In summary, our work uncovers an unprecedented strategy employed by S. flexneri to subvert the key host immune factor RNF213, thereby facilitating bacterial proliferation during invasion.